You do realize Companies are based on valuation --- so, the more shares outstanding the lower the price per share for a given valuation. You're expecting HGEN to shoot back to prior prices, when you're not taking into consideration dilution which means, a lower share price for the same valuation.
Let's try one more example and we'll use round numbers. Let's say we think HGEN is worth $1 billion so we'll use that. Let's say there's 50 million shares outstanding, a $1 billion valuation means a $20 share price. Now let's say Management sells a bunch of shares call it 20 million shares. There has been no change in the business other than the share sale and thus the intrinsic value stays at $1 billion.
Target price prior to dilution - $20 Target price after dilution - $14.29
Thus, HGEN will not shoot back up to same prior levels because there are more shares outstanding, unless HGEN is able to increase the intrinsic value to warrant the same $20 share price --- i.e., HGEN would need to increase intrinsic value $400 million to get back to the $20 share price (i.e. $20 share price x 70 million shares = $1.4 billion vs. $20 x 50 million shares = $1.0 billion).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.